Apixaban versus Warfarin in Patients with Atrial Fibrillation
In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality. (Funded...
Publications
View AllApixaban with Antiplatelet Therapy after Acute Coronary Syndrome
The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding ev...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- ES
- Publications
- 3
- Citations
- 9,678
External Links
Identifiers
- ROR
- https://ror.org/01s1q0w69